Eliglustat + Levoketoconazole Interaction
Contraindicatedinteraction on record
Description
Concomitant use is contraindicated in poor or intermediate CYP2D6 metabolizers and in patients taking CYP2D6 inhibitors due to QT prolongation risk.
Mechanism
CYP3A4 substrate; QT prolongation risk
Source: NLP:levoketoconazole